Video

Terri E. Weaver, PhD, RN, on Efficacy of Solriamfetol for Treating Symptoms of Obstructive Sleep Apnea

01/14/2021

In this video, Terri E. Weaver, PhD, RN, talks about the effectiveness of solriamfetol in improving daily functioning, reducing daytime sleepiness, and enhancing work productivity.

Additional Resource:

Terri E. Weaver, PhD, RN, is dean and professor in the Department of Behavioral Nursing Science in the College of Nursing and professor in the Division of Pulmonary, Critical Care, Sleep, and Allergy in the Department of Medicine in the College of Medicine at the University of Illinois at Chicago.

TRANSCRIPT:

My name is Terri Weaver, I am Dean and professor at the University of Illinois Chicago College of Nursing.

This was a study to look at the effectiveness as opposed to the efficacy of solriamfetol with particular outcomes of daily functioning, daytime sleepiness, and also work productivity, along with perception of change by the patient and also the clinician.

It is approved for daytime sleepiness and patients with obstructive sleep apnea. It’s also approved for the treatment of sleepiness and narcolepsy. It is approved for 3 doses—75 mg, 150 mg, and 300 mg.

The findings showed that when this was evaluated, especially with a withdrawal phase that included a placebo, that the efficacy of solriamfetol was maintained long term, 40 weeks out.

So, the initial studies with clinical trial that was done to prove efficacy of solriamfetol showed that it was efficacious for daytime sleepiness, daily functioning, and work productivity. This study showed that efficacy was maintained long term, which was clinical effectiveness. And so, it has both efficacy and effectiveness

A component of the study was a withdrawal phase where individuals who were on doses that treated their sleepiness, when you withdrew that, in fact, they were still able to see the benefit in several outcomes that were the case with regard to the initial evaluation of the agent and that those who were placed on placebo during that time had a decline.

Thank you for the opportunity to share our work, greatly appreciate it.

Related Content

Primary Care
Primary Care
Manish Jha, MBBS, on Screening and Treating Anxiety Disorders in Primary Care
07/16/2021
In this video, Manish Jha, MBBS, reviews the key take-home points from his session on effectively treating anxiety disorders in primary care, which he presented at our Practical Updates in Primary Care 2021...
07/16/2021
Stress and Burnout
Stress and Burnout
Garret Duron, MD, on 5 Questions to Ask Yourself to Determine Whether a Piece of COVID-19 Literature Will Be Helpful to You
12/11/2020
In his last video, Garret Duron, MD, highlighted the recommendations that he and his team developed for how rheumatologists can navigate the COVID-19 literature landscape. In this video, Dr Duron explains...
12/11/2020
Nutrition
lempert
Nutrition
Phil Lempert on Grocery Shopping During the Pandemic
03/19/2021
In this video, Phil Lempert discusses a recent analysis of data from a nationally representative consumer survey on how the American grocery basket has evolved over the past year.
03/19/2021
Rheumatology
Rheumatology
Integrating Complementary Medicine and Herbs Into the Management of Rheumatic Diseases
01/21/2021
In this video, Neha Shah, MD, explains the benefits you may see by integrating complementary medicine and herbs into the management of your patients with rheumatic diseases. It was a topic she presented...
01/21/2021
Gastroenterology
Manreet Kaur
Gastroenterology
Manreet Kaur, MD, on Whether Precision Medicine is Ready for Prime Time
09/25/2020
In this 4-minute video, Manreet Kaur, MD, reviews her presentation from the virtual Advances in Inflammatory Bowel Disease regional meeting on precision medicine in treatment of IBD.
09/25/2020